Back to CVE records
High 7.5Published Aug 18, 2026

CVE-2026-60393Vulnerability in the Oracle Hyperion Infrastructure Technology product of Oracle Hyperion (component: Lifecycle Management).

Updated under an hour ago ()

Does this affect you?

It affects Oracle Corporation Oracle Hyperion Infrastructure Technology. Add what you run to find out whether that includes you.

No exploitation reported and no EPSS estimate yet.

Vulnerability in the Oracle Hyperion Infrastructure Technology product of Oracle Hyperion (component: Lifecycle Management). The supported version that is affected is 11.2.25.0.000. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Hyperion Infrastructure Technology. Successful attacks of this vulnerability can result in unauthorized access to critical data or complete access to all Oracle Hyperion Infrastructure Technology accessible data. CVSS 3.1 Base Score 7.5 (Confidentiality impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N).

CVSS
7.5 HIGH (v3.1, CNA)CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N
Weakness (CWE)
CWE-200
Known exploited
Not in CISA's KEV catalog
EPSS (exploitation in the next 30 days)
Not loaded for this CVE
Assigned by
oracle
NVD analysis
Analyzed
Record last updated
Aug 20, 2026
First seen by InfoSec Signals
Oct 9, 2026

Affected products

Affected products
Oracle Corporation Oracle Hyperion Infrastructure Technology
oracle:hyperion_infrastructure_technology (from the name)
11.2.25.0.000
CNA record
oracle hyperion_infrastructure_technology
oracle:hyperion_infrastructure_technology
11.2.25.0.000
NVD

References

  • vendor-advisory

The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.

Your cookie choices
We use essential cookies to run this site, and, only with your consent, an advertising cookie from Google to measure whether our ads lead to sign-ups and subscriptions. See our for details.